Viewing Study NCT00410605


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 2:00 AM
Study NCT ID: NCT00410605
Status: COMPLETED
Last Update Posted: 2017-09-01
First Post: 2006-12-11
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization: